| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Medicine, Rajavithi Hospital (T.S., S.N.), and the Department of Pediatrics, Queen Sirikit National Institute of Child Health (S.C.), Bangkok 10400, Thailand
Address all correspondence and requests for reprints to: Thongkum Sunthornthepvarakul, M.D., Rajavithi Hospital, Bangkok 10400, Thailand. E-mail: thongkum{at}rajavithi.go.th
We report a novel mutation of the signal peptide of the prepro-PTH gene associated with autosomal recessive familial isolated hypoparathyroidism. The proposita presented with neonatal hypocalcemic seizures. Serum calcium was 1.5 mmol/L (normal, 2.02.5); phosphate was 3.6 mmol/L (normal, 0.91.5). She was born to consanguineous parents. A few years later, 2 younger sisters and her niece presented with neonatal hypocalcemic seizures. Their intact PTH levels were undetectable during severe hypocalcemia. Genomic DNA from the proposita was sequenced all exons of the prepro-PTH gene. A replacement of thymine with a cytosine was found in the first nucleotide of position 23 in the 25-amino acid signal peptide. This results in the replacement of the normal Ser (TCG) with a Pro (CCG). Genotyping of family members was carried out by identification of a new MspI site created by the mutation. Only affected family members were homozygous for the mutant allele, whereas the parents were heterozygous, supporting autosomal recessive inheritance. As this mutation is at the -3 position in the signal peptide of the prepro-PTH gene, we hypothesized that the prepro-PTH mutant might not be cleaved by signal peptidase at the normal position, and it might be degraded in rough endoplasmic reticulum.
This article has been cited by other articles:
![]() |
M. Mannstadt, G. Bertrand, M. Muresan, G. Weryha, B. Leheup, S. R. Pulusani, B. Grandchamp, H. Juppner, and C. Silve Dominant-Negative GCMB Mutations Cause an Autosomal Dominant Form of Hypoparathyroidism J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3568 - 3576. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Shoback Hypoparathyroidism N. Engl. J. Med., July 24, 2008; 359(4): 391 - 403. [Full Text] [PDF] |
||||
![]() |
A. Maret, C. Ding, S. L. Kornfield, and M. A. Levine Analysis of the GCM2 Gene in Isolated Hypoparathyroidism: A Molecular and Biochemical Study J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1426 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Datta, A. Waheed, G. N. Shah, and W. S. Sly Signal sequence mutation in autosomal dominant form of hypoparathyroidism induces apoptosis that is corrected by a chemical chaperone PNAS, December 11, 2007; 104(50): 19989 - 19994. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Y. Chiu, H.-W. Chen, H.-W. Chao, L.-T. Yann, and K.-S. Tsai Identification of Three Novel Mutations in the GATA3 Gene Responsible for Familial Hypoparathyroidism and Deafness in the Chinese Population J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4587 - 4592. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rao Vupputuri, R. Goswami, N. Gupta, D. Ray, N. Tandon, and N. Kumar Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptor gene polymorphisms in Asian Indians Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1411 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Talmud, J. Palmen, W. Putt, L. Lins, and S. E. Humphries Determination of the Functionality of Common APOA5 Polymorphisms J. Biol. Chem., August 5, 2005; 280(31): 28215 - 28220. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xue, A. C. Karaplis, G. N. Hendy, D. Goltzman, and D. Miao Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development Hum. Mol. Genet., June 1, 2005; 14(11): 1515 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Baumber, C Tufarelli, S Patel, P King, C A Johnson, E R Maher, and R C Trembath Identification of a novel mutation disrupting the DNA binding activity of GCM2 in autosomal recessive familial isolated hypoparathyroidism J. Med. Genet., May 1, 2005; 42(5): 443 - 448. [Full Text] [PDF] |
||||
![]() |
Y. Baba, D. F. Broderick, R. J. Uitti, M. L. Hutton, and Z. K. Wszolek Heredofamilial Brain Calcinosis Syndrome Mayo Clin. Proc., May 1, 2005; 80(5): 641 - 651. [Abstract] [PDF] |
||||
![]() |
R. Gensure and H. Juppner Parathyroid Hormone without Parathyroid Glands Endocrinology, February 1, 2005; 146(2): 544 - 546. [Full Text] [PDF] |
||||
![]() |
R. Goswami, T. Mohapatra, N. Gupta, R. Rani, N. Tomar, A. Dikshit, and R. K. Sharma Parathyroid Hormone Gene Polymorphism and Sporadic Idiopathic Hypoparathyroidism J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4840 - 4845. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eichenbaum-Voline, M. Olivier, E. L. Jones, R. P. Naoumova, B. Jones, B. Gau, H. N. Patel, M. Seed, D. J. Betteridge, D. J. Galton, et al. Linkage and Association Between Distinct Variants of the APOA1/C3/A4/A5 Gene Cluster and Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 167 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jiang, T. Lamminen, P. Pakarinen, J. Hellman, P. Manna, R. J. Herrera, and I. Huhtaniemi A novel Ala-3Thr mutation in the signal peptide of human luteinizing hormone {beta}-subunit: potentiation of the inositol phosphate signalling pathway and attenuation of the adenylate cyclase pathway by recombinant variant hormone Mol. Hum. Reprod., March 1, 2002; 8(3): 201 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Marx Hyperparathyroid and Hypoparathyroid Disorders N. Engl. J. Med., December 21, 2000; 343(25): 1863 - 1875. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |